Literature DB >> 19038583

Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea.

Ingrid Chantler1, Duncan Mitchell, Andrea Fuller.   

Abstract

UNLABELLED: We assessed the efficacy of diclofenac potassium, a nonsteroidal anti-inflammatory drug, in alleviating menstrual pain and restoring exercise performance to that measured in the late-follicular phase of the menstrual cycle. Twelve healthy young women with a history of primary dysmenorrhea completed, in a random order, laboratory exercise-testing sessions when they were in the late-follicular (no menstruation, no pain) phase of the menstrual cycle and when they were experiencing dysmenorrhea and receiving, in a double-blinded fashion, either 100 mg of diclofenac potassium or placebo. We assessed the women's leg strength (1-repetition maximum test), aerobic capacity (treadmill walking test), and ability to perform a functional test (task-specific test). Compared with placebo, diclofenac potassium significantly decreased dysmenorrhea on the day of administration (Visual Analog Scale, P < .001 at all times). When receiving placebo for menstrual pain, the women's performance in the tests was decreased significantly, compared with when they were receiving diclofenac potassium for menstrual pain (P < .05) and compared with when they were in the late-follicular phase of the menstrual cycle (P < .05 for treadmill test, P < .01 for task-specific test and 1-repetition maximum test). Administration of diclofenac potassium for menstrual pain restored exercise performance to a level not different from that achieved in the late-follicular phase of the cycle. PERSPECTIVE: In women with primary dysmenorrhea, menstrual pain, if untreated, decreases laboratory-assessed exercise performance. A recommended daily dose of a readily available nonsteroidal anti-inflammatory drug, diclofenac potassium, is effective in relieving menstrual pain and restoring physical performance to levels achieved when the women were in the late-follicular (no menstruation, no pain) phase of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038583     DOI: 10.1016/j.jpain.2008.08.006

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  13 in total

1.  Menstrual cycle effects on perceived exertion and pain during exercise among sedentary women.

Authors:  Ann E Caldwell Hooper; Angela D Bryan; Melissa Eaton
Journal:  J Womens Health (Larchmt)       Date:  2011-01-10       Impact factor: 2.681

2.  Involvement of a neutrophil-mast cell axis in the effects of Piper malacophyllum (C. PESL) C. DC extract and its isolated compounds in a mouse model of dysmenorrhoea.

Authors:  Nara Lins Meira Quintão; Jaqueline Pavesi Reis; Larissa Benvenutti; Roberta Nunes; Fernanda Capitanio Goldoni; Manuela Somensi Cozer; Priscila de Souza; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Jessica Melato; Carlos Rafael Vaz; Juliana Cristina Pereira Whitaker; Flavia Werner Jesuíno; Mariana Couto Costa; Maria Verônica Dávila Pastor; Angela Malheiros; Christiane Meyre-Silva; José Roberto Santin
Journal:  Inflammopharmacology       Date:  2022-07-22       Impact factor: 5.093

3.  Are health promoting lifestyles associated with pain intensity and menstrual distress among Iranian adolescent girls?

Authors:  Elahe Cholbeigi; Shaghayegh Rezaienik; Narges Safari; Kerrie Lissack; Mark D Griffiths; Zainab Alimoradi
Journal:  BMC Pediatr       Date:  2022-10-05       Impact factor: 2.567

4.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

5.  Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Authors:  Vincent T Martin; Jeanne Ballard; Michael P Diamond; Lisa K Mannix; Frederick J Derosier; Shelly E Lener; Alok Krishen; Susan A McDonald
Journal:  J Womens Health (Larchmt)       Date:  2014-02-28       Impact factor: 2.681

Review 6.  Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

Authors:  Jane Marjoribanks; Reuben Olugbenga Ayeleke; Cindy Farquhar; Michelle Proctor
Journal:  Cochrane Database Syst Rev       Date:  2015-07-30

7.  Diclofenac potassium restores objective and subjective measures of sleep quality in women with primary dysmenorrhea.

Authors:  Stella Iacovides; Ingrid Avidon; Alison Bentley; Fiona C Baker
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

8.  Comparing the effects of aerobic and stretching exercises on the intensity of primary dysmenorrhea in the students of universities of bushehr.

Authors:  Farideh Vaziri; Azam Hoseini; Farahnaz Kamali; Khadijeh Abdali; Mohamadjavad Hadianfard; Mehrab Sayadi
Journal:  J Family Reprod Health       Date:  2015-03

9.  Auricular acupressure to improve menstrual pain and menstrual distress and heart rate variability for primary dysmenorrhea in youth with stress.

Authors:  Yu-Jen Wang; Chin-Che Hsu; Mei-Ling Yeh; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-12       Impact factor: 2.629

10.  The Effect of aerobic exercise on primary dysmenorrhea: A clinical trial study.

Authors:  Zahra Mohebbi Dehnavi; Farzaneh Jafarnejad; Zahra Kamali
Journal:  J Educ Health Promot       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.